<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tobe BTD</submitter><funding>HHS | NIH | National Institute of Mental Health</funding><funding>NIDA NIH HHS</funding><funding>NIMH NIH HHS</funding><pagination>E4462-E4471</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5465887</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>114(22)</volume><pubmed_abstract>The molecular pathogenesis of bipolar disorder (BPD) is poorly understood. Using human-induced pluripotent stem cells (hiPSCs) to unravel such mechanisms in polygenic diseases is generally challenging. However, hiPSCs from BPD patients responsive to lithium offered unique opportunities to discern lithium's target and hence gain molecular insight into BPD. By profiling the proteomics of BDP-hiPSC-derived neurons, we found that lithium alters the phosphorylation state of collapsin response mediator protein-2 (CRMP2). Active nonphosphorylated CRMP2, which binds cytoskeleton, is present throughout the neuron; inactive phosphorylated CRMP2, which dissociates from cytoskeleton, exits dendritic spines. CRMP2 elimination yields aberrant dendritogenesis with diminished spine density and lost lithiu</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.</pubmed_title><pmcid>PMC5465887</pmcid><funding_grant_id>RC2MH090011</funding_grant_id><funding_grant_id>K01 DA038654</funding_grant_id><funding_grant_id>R21 MH093958</funding_grant_id><funding_grant_id>R33MH087896</funding_grant_id><funding_grant_id>R01 MH087823</funding_grant_id><funding_grant_id>RC2 MH090011</funding_grant_id><funding_grant_id>R33 MH087896</funding_grant_id><funding_grant_id>R01 MH095088</funding_grant_id><funding_grant_id>R01MH095088</funding_grant_id><funding_grant_id>R21MH093958</funding_grant_id><pubmed_authors>McCarthy MJ</pubmed_authors><pubmed_authors>Goshima Y</pubmed_authors><pubmed_authors>Zhao WN</pubmed_authors><pubmed_authors>Wu D</pubmed_authors><pubmed_authors>Logan RW</pubmed_authors><pubmed_authors>Basa RCB</pubmed_authors><pubmed_authors>Pernia CD</pubmed_authors><pubmed_authors>Udeshi ND</pubmed_authors><pubmed_authors>Ohshima T</pubmed_authors><pubmed_authors>Konopaske G</pubmed_authors><pubmed_authors>Rouleau GA</pubmed_authors><pubmed_authors>Sheridan SD</pubmed_authors><pubmed_authors>Tobe BTD</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Duerr C</pubmed_authors><pubmed_authors>Nakamura H</pubmed_authors><pubmed_authors>Price JH</pubmed_authors><pubmed_authors>Nakamura F</pubmed_authors><pubmed_authors>Chen G</pubmed_authors><pubmed_authors>Snyder EY</pubmed_authors><pubmed_authors>Brill LM</pubmed_authors><pubmed_authors>Akiskal HS</pubmed_authors><pubmed_authors>Wada M</pubmed_authors><pubmed_authors>Carr SA</pubmed_authors><pubmed_authors>Hunsberger J</pubmed_authors><pubmed_authors>Makihara H</pubmed_authors><pubmed_authors>Mertins P</pubmed_authors><pubmed_authors>Dorsett L</pubmed_authors><pubmed_authors>Gutierrez GJ</pubmed_authors><pubmed_authors>Inoue Y</pubmed_authors><pubmed_authors>Nye JS</pubmed_authors><pubmed_authors>Alda M</pubmed_authors><pubmed_authors>Mikoshiba K</pubmed_authors><pubmed_authors>Chuang DM</pubmed_authors><pubmed_authors>Teng YD</pubmed_authors><pubmed_authors>Mastrangelo L</pubmed_authors><pubmed_authors>McClung CA</pubmed_authors><pubmed_authors>Haggarty SJ</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Coyle JT</pubmed_authors><pubmed_authors>Crain AM</pubmed_authors><pubmed_authors>Venizelos N</pubmed_authors><pubmed_authors>Manji H</pubmed_authors><pubmed_authors>Halpain S</pubmed_authors><pubmed_authors>Sidman RL</pubmed_authors><pubmed_authors>Lalonde J</pubmed_authors><pubmed_authors>Winquist AM</pubmed_authors><pubmed_authors>Brandel M</pubmed_authors><pubmed_authors>Calabrese B</pubmed_authors><pubmed_authors>Sidor M</pubmed_authors><pubmed_authors>Yamashita N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.</name><description>The molecular pathogenesis of bipolar disorder (BPD) is poorly understood. Using human-induced pluripotent stem cells (hiPSCs) to unravel such mechanisms in polygenic diseases is generally challenging. However, hiPSCs from BPD patients responsive to lithium offered unique opportunities to discern lithium's target and hence gain molecular insight into BPD. By profiling the proteomics of BDP-hiPSC-derived neurons, we found that lithium alters the phosphorylation state of collapsin response mediator protein-2 (CRMP2). Active nonphosphorylated CRMP2, which binds cytoskeleton, is present throughout the neuron; inactive phosphorylated CRMP2, which dissociates from cytoskeleton, exits dendritic spines. CRMP2 elimination yields aberrant dendritogenesis with diminished spine density and lost lithiu</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 May</publication><modification>2026-05-05T02:57:49.644Z</modification><creation>2025-06-01T03:33:37.723Z</creation></dates><accession>S-EPMC5465887</accession><cross_references><pubmed>28500272</pubmed><doi>10.1073/pnas.1700111114</doi></cross_references></HashMap>